CD8A and neoplasm: It has been well documented that patients' clinical outcome and five-year survival rate are positively associated with the number of tumor-infiltrating lymphocytes (TILs) [2], and the ratio of intraepithelial CD8+ TILs to TReg cells [3], or negatively associated with tumor- infiltrating TReg cells [4].